BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pitolisant (Wakix) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Pitolisant (Wakix)\, from ClinicalTrials.
 gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06366464-1724@assetmemo.bio
DTSTAMP:20261121T005622Z
DTSTART;VALUE=DATE:20270430
DTEND;VALUE=DATE:20270501
SUMMARY:Pitolisant (Wakix): Phase 3 readout est. (NCT06366464)
DESCRIPTION:Pitolisant (Wakix)\, phase 3\, Prader-Willi Syndrome.\nStudy: A
  Study of Pitolisant in Patients With Prader-Willi Syndrome\nEstimated pri
 mary completion: April 2027. This is a ClinicalTrials.gov estimate\, not a
  confirmed readout date\, and it can move.\nDrug page: https://assetmemo.b
 io/drug/pitolisant-wakix#upcoming-events\nRegistry record: https://clinica
 ltrials.gov/study/NCT06366464
URL:https://assetmemo.bio/drug/pitolisant-wakix#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07219485-1724@assetmemo.bio
DTSTAMP:20261121T005622Z
DTSTART;VALUE=DATE:20300831
DTEND;VALUE=DATE:20300901
SUMMARY:Pitolisant (Wakix): Phase 3 readout est. (NCT07219485)
DESCRIPTION:Pitolisant (Wakix)\, phase 3\, Prader-Willi Syndrome.\nStudy: A
  Study of Pitolisant in Participants With Prader-Willi Syndrome\nEstimated
  primary completion: August 2030. This is a ClinicalTrials.gov estimate\, 
 not a confirmed readout date\, and it can move.\nDrug page: https://assetm
 emo.bio/drug/pitolisant-wakix#upcoming-events\nRegistry record: https://cl
 inicaltrials.gov/study/NCT07219485
URL:https://assetmemo.bio/drug/pitolisant-wakix#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
